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Presence of Region of Difference 1 among Clinical Isolates of
Mycobacterium tuberculosis from India
Region of difference 1 (RD1) was first described by Mahai-
ras et al. (4) as a region that is present in all virulent laboratory
and clinical strains of Mycobacterium bovis and Mycobacterium
tuberculosis. This region comprises nine genes (Rv3871 to
Rv3879c) and spans a 9.5-kb region. In M. bovis BCG, RD1
deletion completely removes seven genes (Rv3872 to Rv3878)
and truncates two others (Rv3871 and Rv3879c) (3). Recently
Rao et al. (5) reported the total absence of RD1 in clinical
isolates from India. Since this region has genes that are im-
portant in immunogenicity (ESAT6 and CFP10 genes) and
RD1 deletion mutants of M. tuberculosis have been found to be
less virulent (3), it was important to study this region in other
Indian isolates. In this study, we analyzed 120 M. tuberculosis
isolates from different parts of Kerala and 23 other isolates, 14
from west India and 9 from north India (mainly from Mumbai
and Agra). All these isolates were characterized by biochemi-
cal analysis and IS6110 restriction fragment length polymor-
phism typing. The IS6110 copy number ranged from 0 to 15,
with the majority (70%) representing the “low-copy-number”
group. The presence of the RD1 region was checked with three
sets of primers. The locations of the primers on the H37Rv
genome and the sizes of the expected amplicon and the refer-
ence are indicated in Fig. 1.
Among the isolates from Kerala, esxB and esxA were con-
served in all the isolates (120/120) and Rv3871 and Rv3872
were present in all except 2 (118/120). Rv3878, being present in
only 107 of the 120 isolates, was the least conserved among the
three regions. In the other 23 isolates, we found that esxA and
esxB were present in all but 1 and that the Rv3878 region was
present in 20 isolates. But the Rv3871 and Rv3872 genes were
present only in seven isolates.
Thus, PCR analysis revealed that the entire RD1 region is
not absent in field strains from India. Our earlier study on the
identification of the moaA3 gene had shown that the RD1
region is present in isolates from Kerala (6). In the other
report, Rao et al. (5) had used two sets of primers, one span-
ning the entire RD1 (9.8-kb) region and the other for ampli-
fication of Rv3878. The amplification of the 9.5-kb RD1 region
by routine PCR is technically demanding, and truncation of the
genes or any mutation at the primer binding site would elim-
inate the PCR product. But Rv3878 should have been ampli-
fied, as our study shows that this gene is reasonably well rep-
resented in the isolates from different parts of the country. As
all the 30 strains tested by Rao et al. came from a hospital in
Hyderabad, it may be possible that a pocket of RD1-deficient
strains are concentrated in that area. Beyond that we are un-
able to speculate on the absence of the RD1 region in all the
isolates tested. Rao et al. had downplayed the role of RD1 in
virulence and suggested the possibility of alternate virulence
mechanisms. But all the isolates that we checked were recov-
ered from patients with active tuberculosis and had a signifi-
cant portion of the RD1 region intact. In addition, serological
analysis of patients from the Mumbai region has shown excel-
lent responses to CFP10 and ESAT6 (Dr. Camilla Rodrigues,
personal communication), indicating that these are expressed
in infected patients. Thus, in conclusion, while regional differ-
ences are present in the RD1 region, there appears to be no
universal absence of RD1 in the isolates from the country as a
whole.
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